A phase 1 dose escalation study of BI 831266, an inhibitor of Aurora kinase B, in patients with advanced solid tumors

Overview of attention for article published in Investigational New Drugs, December 2014

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 32 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 61 followers.

A phase 1 dose escalation study of BI 831266, an inhibitor of Aurora kinase B, in patients with... http://t.co/wyQa8Rj2Ze

Reply Repost Favourite